Logotype for Rubicon Organics Inc

Rubicon Organics (ROMJ) Q2 2026 earnings summary

Event summary combining transcript, slides, and related documents.

Logotype for Rubicon Organics Inc

Q2 2026 earnings summary

12 Aug, 2026

Executive summary

  • Achieved record Q2 2026 net revenue of CAD 18.5 million, up 23% year-over-year and 35% sequentially, with six-month revenue at CAD 32.1 million, driven by premium-focused strategy and operational improvements at Pacifica.

  • Growth realized across all three key brands in Canada and initial international sales, with Cascadia facility contributing revenue for the first time.

  • Maintained number one national market share in premium flower at 9.7%, with gains in premium pre-rolls and continued brand recognition.

  • Successfully launched the 1964 brand in the U.K. medical cannabis market, marking the first international commercial launch.

  • Cascadia facility operationalized on budget and on schedule, with initial harvests meeting premium quality standards and revenues beginning to be realized.

Financial highlights

  • Q2 2026 net revenue reached CAD 18.5 million, a 23% increase year-over-year and 35% sequentially.

  • Gross margin before fair value adjustments was 30%; excluding pre-revenue Cascadia costs, gross margin was 36%, the highest since Q4 2024.

  • Adjusted EBITDA was positive at CAD 1.1 million, down from CAD 1.4 million in Q2 2025 due to costs of operating a larger platform.

  • SG&A expenses were CAD 6.9 million, up CAD 2 million year-over-year, reflecting investments in talent, brand, and regulatory costs.

  • Ended the quarter with CAD 3 million in cash and CAD 20.9 million in working capital.

Outlook and guidance

  • Net revenue and Adjusted EBITDA expected to ramp up through Q3 and Q4 2026 as Cascadia scales and operational efficiencies improve.

  • International revenue projected to average 10% of total revenue for fiscal 2026, with further expansion anticipated in 2027.

  • Ongoing initiatives in yield improvement, automation, and in-house extraction expected to drive margin and EBITDA growth.

  • 2026 is viewed as an inflection point, with ongoing optimization and investments supporting future revenue and margin growth.

  • Current annual production capacity is 15,500 kg, with a pathway to 20,000 kg over 18–24 months.

Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.
All investor relations material. One API.
Learn more